Added | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34635 of 34949  at  6/15/2019 12:41:11 PM  by

evernewbliss


 In response to msg 34628 by  Southerncross1
view thread

Re: Added

They will be reporting data on AB-506 in July. If the data is good and safe, ABUS can easily double from the current low valuation of only ~$1.50. There will be a lot of opportunities to license out AB-506 to companies like ALNY/VIR or DRNA. They may be interested in licensing that drug since they donít have capsid inhibitors for combination trial. I donít see anything wrong in licensing AB-506 to potential competitors since it will only expand the market opportunity for AB-506.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 188
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...